URGN•benzinga•
Reported Sunday, UroGen's OPTIMA II Study Results Show UGN-102 Delivers Median 24.2-Month Duration Of Response In Recurrent LG-IR-NMIBC
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga